Characterization of the role of IS256 in the development of intermediate vancomycin resistance in a clinical Staphylococcus aureus isolate

被引:0
|
作者
Nagel, M. [1 ]
Jansen, A. [1 ]
Tuerck, M. [1 ]
Bierbaum, G. [1 ]
机构
[1] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-5300 Bonn, Germany
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:65 / 66
页数:2
相关论文
共 50 条
  • [41] Clinical and Molecular Characterization of Invasive Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Infections in Korean Hospitals
    Kim, Eu Suk
    Bae, In-Gyu
    Cho, Jeong Eun
    Choi, Yun Jung
    Kim, Il-Hwan
    Kang, Gi-Su
    Sin, Hye-yun
    Song, Kyoung-Ho
    Park, Chulmin
    Lee, Dong-Gun
    Kim, Moonsuk
    Park, Kyoung Un
    Kim, Hong Bin
    JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (03) : 760 - 763
  • [42] Heterogeneous resistance to vancomycin in Staphylococcus aureus
    Howe, RA
    Wootton, M
    Walsh, TR
    Bennett, PM
    MacGowan, AP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) : 130 - 131
  • [43] Mechanisms of vancomycin resistance in Staphylococcus aureus
    Gardete, Susana
    Tomasz, Alexander
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (07): : 2836 - 2840
  • [44] Vancomycin Resistance in Enterococcus and Staphylococcus aureus
    Li, Gen
    Walker, Mark J.
    De Oliveira, David M. P.
    MICROORGANISMS, 2023, 11 (01)
  • [45] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    Fong, R. K. C.
    Low, J.
    Koh, T. H.
    Kurup, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (08) : 983 - 987
  • [46] Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
    R. K. C. Fong
    J. Low
    T. H. Koh
    A. Kurup
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28
  • [47] Characterization of a Vancomycin Intermediate-Resistant Staphylococcus aureus Isolated from a Hospital
    Mirani, Zulfiqar Ali
    Jamil, Nusrat
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (08): : 558 - 559
  • [48] Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
    Lin, Lee-Chung
    Chang, Shih-Cheng
    Ge, Mao-Cheng
    Liu, Tsui-Ping
    Lu, Jang-Jih
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 113 - 123
  • [49] IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate
    Kuroda, Makoto
    Sekizuka, Tsuyoshi
    Matsui, Hidehito
    Ohsuga, Jun
    Ohshima, Toshio
    Hanaki, Hideaki
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [50] First report of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in Mainland China
    Zhang, Xia
    Hu, Qiwen
    Yuan, Wenchang
    Shang, Weilong
    Cheng, Hang
    Yuan, Jizhen
    Zhu, Junmin
    Hu, Zhen
    Li, Shu
    Chen, Wei
    Hu, Xiaomei
    Rao, Xiancai
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 77 (01) : 64 - 68